Hellen Joly

Hellen Joly is an accomplished drug development professional with over 20 years of experience in Clinical Research and Operations, currently serving as the Associate Director of Risk Based Quality Management at Gilead Sciences. They have a robust background in managing clinical trials across various therapeutic areas, including Inflammation, Diabetes, Neuroscience, and Oncology, with a focus on Early Phase studies. Previously, Hellen held senior roles at Eli Lilly and Charterhouse Clinical Research, contributing significantly to clinical project management and operational leadership. They are committed to volunteerism and corporate responsibility, and currently pursue a Master's in Clinical Trials at The University of Edinburgh.